Literature DB >> 11705686

Therapy of pemphigus.

G G Tóth1, M F Jonkman.   

Abstract

Mesh:

Substances:

Year:  2001        PMID: 11705686     DOI: 10.1016/s0738-081x(00)00190-5

Source DB:  PubMed          Journal:  Clin Dermatol        ISSN: 0738-081X            Impact factor:   3.541


× No keyword cloud information.
  5 in total

1.  Complete FcRn dependence for intravenous Ig therapy in autoimmune skin blistering diseases.

Authors:  Ning Li; Minglang Zhao; Julio Hilario-Vargas; Phillip Prisayanh; Simon Warren; Luis A Diaz; Derry C Roopenian; Zhi Liu
Journal:  J Clin Invest       Date:  2005-11-10       Impact factor: 14.808

2.  [Gold. Effective therapy for mucosal lesions of pemphigus vulgaris].

Authors:  D Lange; F Meiss; E Fiedler; K Treiber; W C Marsch; M Fischer
Journal:  Hautarzt       Date:  2007-02       Impact factor: 0.751

3.  Rituximab is an effective treatment in patients with pemphigus vulgaris and demonstrates a steroid-sparing effect.

Authors:  D M Chen; A Odueyungbo; E Csinady; L Gearhart; P Lehane; M Cheu; M Maho-Vaillant; C Prost-Squarcioni; V Hebert; E Houivet; S Calbo; F Caillot; M L Golinski; B Labeille; C Picard-Dahan; C Paul; M A Richard; J D Bouaziz; S Duvert-Lehembre; P Bernard; F Caux; M Alexandre; S Ingen-Housz-Oro; P Vabres; E Delaporte; G Quereux; A Dupuy; S Debarbieux; M Avenel-Audran; M D'Incan; C Bedane; N Bénéton; D Jullien; N Dupin; L Misery; L Machet; M Beylot-Barry; O Dereure; B Sassolas; J Benichou; P Musette; P Joly
Journal:  Br J Dermatol       Date:  2019-11-28       Impact factor: 9.302

4.  Rituximab in the treatment of pemphigus vulgaris.

Authors:  Labib R Zakka; Shawn S Shetty; A Razzaque Ahmed
Journal:  Dermatol Ther (Heidelb)       Date:  2012-11-15

5.  Oral Pemphigus Vulgaris: Case Report.

Authors:  Rai Arpita; Arora Monica; Naikmasur Venkatesh; Sattur Atul; Malhotra Varun
Journal:  Ethiop J Health Sci       Date:  2015-10
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.